19^thGlobal Summit on Hematology and Infectious Diseases July 31-01, 2023 Madrid, Spain

Hemostasis and thrombosis are two closely connected processes that are essential to the body's capacity to keep blood flowing and stop bleeding.

A blood clot (thrombus) that forms inside a blood artery and can either totally or partially impede blood flow is referred to as thrombosis. Serious medical disorders such deep vein thrombosis, pulmonary embolism, stroke, and heart attack can result from this.

On the other side, hemostasis describes the body's innate capacity to halt bleeding following an accident or damage to a blood artery. Blood vessel constriction, platelet activation and aggregation, and the creation of a fibrin clot to close the wound are all processes in the hemostatic process.

A category of medical illnesses known as bleeding disorders cause excessive or protracted bleeding after an accident or surgery because the blood cannot clot correctly. There are two primary categories of bleeding disorders:

Haemophilia is a clotting factor VIII (haemophilia A) or IX (haemophilia B) deficiency-related hereditary bleeding condition.

vWD, or von Willebrand disease This is the most prevalent hereditary bleeding condition and is brought on by a lack of or malfunction in the protein known as von Willebrand factor, which is essential for platelet activity and clotting.

Other bleeding conditions include coagulation factor deficits, such as factor XI deficiency, and platelet diseases include immune thrombocytopenia (ITP) and thrombotic thrombocytopenic purpura (TTP).

In the medical technique known as hematopoietic stem cell transplantation (HSCT), healthy stem cells are used to replace sick or damaged bone marrow. Both a donor and a patient's own body can provide stem cells for HSCT (allogeneic transplant) or the patient's own body (autologous transplant).

In order to treat or cure illnesses like leukaemia, lymphoma, and other blood-related disorders, HSCT aims to supply fresh, healthy stem cells that can create new blood cells.

HSCT comes in a variety of forms, such as myeloablative and non-myeloablative transplants. In contrast to non-myeloablative transplants, myeloablative transplants employ greater dosages of chemotherapy and radiation therapy.

Infection, graft-versus-host disease (GVHD), and organ damage are a few of the serious hazards and adverse effects of HSCT.

Immunotherapy is a sort of treatment that harnesses the immune system of the patient to combat illnesses, particularly blood problems. It entails the use of medications or other substances to enhance the immune system's capacity to spot and eliminate cancer cells or other aberrant cells.

Hematologic illnesses include extremes in cellular component problems, insufficiencies or damage, and dysfunction. Neurologic impairment may be caused by the majority of diseases. Some of these issues are extremely exclusive to the hematologic complaint anaemia, while others are widespread. Hematologic illnesses and the related neurologic conditions are the topic of this session.

The science used to treat cancer and other diseases including blood abnormalities is called hematology-oncology (oncology). Additionally, it heals blood malignancies, various diseases such iron deficiency anaemia and thalassemia, as well as tumours of other organs. The course of treatment for a person with myeloma will vary depending on a number of variables. In the case of multiple myeloma, this includes a time known as the smouldering stage, in which there are no obvious symptoms and the myeloma cells in the body are not progressing.

Protein biomarkers are particularly useful for identifying breast growth and can be used as biomarkers for early tumour localization. Symptomatic an underlying CT sweep will be performed on patients with probable pancreatic cancer to see whether a tumour may be surgically contained and removed. By performing an H&E neurotic examination, it will be established that 63% of patients have stage III or stage IV illnesses that are not treatable, and a biopsy will be attempted to confirm pancreatic disease. 

The field of hematology known as immunohematology, commonly known as blood management, examines antigen-counteracting agent responses and comparative studies as they relate to the pathophysiology and clinical symptoms of blood issues. Those who operate in this area are known as immuno-hematologists. Cross-coordinating, blood writing, and immune response identifiable proof are among their standard requirements. This area oversees the planning of blood donations, blood components, and other beneficial blood transfusion segments. Due to prior exposure to RBCs from other individuals, as frequently as feasible through pregnancy or transfusion, individuals may have developed a resistance to RBCs. 

Reports of clinical and experimental work in the disciplines of clinical chemistry, hematology, immunology, cancer, and virology are published in Clinical and Experimental Medicine. Clarity, experimental soundness, and knowledge advancements will be the primary evaluation criteria for publications. New clinical or experimental papers that have the potential to influence how clinicians treat patients or think about diseases will be given priority due to their importance now. 

Lack of sufficient numbers of healthy red blood cells to adequately oxygenate the body's tissues is known as Anemia. If you have anaemia, you could feel exhausted and weakened. Anemia can have many different forms, each with a unique aetiology. Anemia can range from mild to severe, and it can be short-term or long-term.

Myeloma, commonly referred to as multiple myeloma, is a blood cancer that develops from plasma cells. It can be benign or malignant. In the UK, there are approximately 17,500 myeloma patients at any given moment. It is responsible for 2% of all malignancies and 15% of blood cancers. Myeloma primarily affects those over 65, but it has been identified in those as young as 20.

The inability of the blood to coagulate (form clots) is known as coagulopathy. This disorder may result in a propensity for prolonged or heavy bleeding, which may happen naturally or after an injury or certain medical and dental procedures.

Leukemia is a malignancy that typically develops in the bone marrow, which produces blood. It causes an excess of aberrant white blood cells, a component of the immune system that protects the body from infection, to be produced.

A blood condition called thalassemia is inherited and is characterised by the body producing either an abnormal form or insufficient amounts of haemoglobin. The protein that carries oxygen in red blood cells is called haemoglobin. Anemia is brought on by the disorder's large-scale destruction of red blood cells.

A range of illnesses brought on by infection with the human immunodeficiency virus are known as HIV infection and acquired immune deficiency syndrome (HIV/AIDS) (HIV). Usually, a protracted interval without symptoms comes next. As the infection worsens, it causes additional immune system interference, raising the chance of acquiring opportunistic infections, malignancies, and common illnesses like tuberculosis that seldom affect people with healthy immune systems. The term "acquired immunodeficiency syndrome" refers to these post-infection symptoms (AIDS). Unintentional weight loss is frequently correlated with this period as well.